Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)

Peer review reports

Original Submission
3 Mar 2021	Submitted	Original manuscript
29 Jun 2021	Reviewed	Reviewer Report - Muslim Syed
4 Jul 2021	Reviewed	Reviewer Report - Xinsen Xu
21 Jul 2021	Author responded	Author comments - Daisaku Yamada
Resubmission - Version 2
21 Jul 2021	Submitted	Manuscript version 2
27 Jul 2021	Reviewed	Reviewer Report - Muslim Syed
1 Aug 2021	Reviewed	Reviewer Report - Xinsen Xu
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 Aug 2021	Editorially accepted
26 Aug 2021	Article published	10.1186/s13063-021-05541-w

Back to article page